ID   RYR3_RABIT              Reviewed;        4872 AA.
AC   Q9TS33;
DT   22-FEB-2012, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   22-FEB-2023, entry version 136.
DE   RecName: Full=Ryanodine receptor 3;
DE            Short=RYR-3;
DE            Short=RyR3;
DE   AltName: Full=Brain ryanodine receptor-calcium release channel;
DE   AltName: Full=Brain-type ryanodine receptor;
DE   AltName: Full=Type 3 ryanodine receptor;
OS   Oryctolagus cuniculus (Rabbit).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Lagomorpha; Leporidae; Oryctolagus.
OX   NCBI_TaxID=9986;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=1330694; DOI=10.1016/0014-5793(92)80941-9;
RA   Hakamata Y., Nakai J., Takeshima H., Imoto K.;
RT   "Primary structure and distribution of a novel ryanodine receptor/calcium
RT   release channel from rabbit brain.";
RL   FEBS Lett. 312:229-235(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3), FUNCTION, SUBCELLULAR
RP   LOCATION, REGULATION BY RYANODINE; CALMODULIN; CALCIUM LEVELS; MAGNESIUM;
RP   ATP; CAFFEINE AND RUTHENIUM RED, AND TISSUE SPECIFICITY.
RC   TISSUE=Uterus;
RX   PubMed=9305876; DOI=10.1074/jbc.272.39.24234;
RA   Chen S.R., Li X., Ebisawa K., Zhang L.;
RT   "Functional characterization of the recombinant type 3 Ca2+ release channel
RT   (ryanodine receptor) expressed in HEK293 cells.";
RL   J. Biol. Chem. 272:24234-24246(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3 AND 4), ALTERNATIVE SPLICING,
RP   FUNCTION, SUBUNIT, INTERACTION WITH RYR2, AND TISSUE SPECIFICITY.
RC   TISSUE=Uterus;
RX   PubMed=12471029; DOI=10.1074/jbc.m210410200;
RA   Jiang D., Xiao B., Li X., Chen S.R.;
RT   "Smooth muscle tissues express a major dominant negative splice variant of
RT   the type 3 Ca2+ release channel (ryanodine receptor).";
RL   J. Biol. Chem. 278:4763-4769(2003).
RN   [4]
RP   FUNCTION, SUBUNIT, AND MUTAGENESIS OF GLU-3885.
RX   PubMed=9614063; DOI=10.1074/jbc.273.24.14675;
RA   Chen S.R., Ebisawa K., Li X., Zhang L.;
RT   "Molecular identification of the ryanodine receptor Ca2+ sensor.";
RL   J. Biol. Chem. 273:14675-14678(1998).
RN   [5]
RP   FUNCTION, SUBUNIT, DOMAIN, INTERACTION WITH FKBP1A, SUBCELLULAR LOCATION,
RP   MEMBRANE TOPOLOGY, ELECTRON MICROSCOPY, REGULATION BY RYANODINE; CALCIUM
RP   LEVELS; MAGNESIUM; ATP AND CAFFEINE, AND TISSUE SPECIFICITY.
RX   PubMed=10358090; DOI=10.1074/jbc.274.24.17297;
RA   Murayama T., Oba T., Katayama E., Oyamada H., Oguchi K., Kobayashi M.,
RA   Otsuka K., Ogawa Y.;
RT   "Further characterization of the type 3 ryanodine receptor (RyR3) purified
RT   from rabbit diaphragm.";
RL   J. Biol. Chem. 274:17297-17308(1999).
RN   [6]
RP   INTERACTION WITH RYR2, AND FUNCTION.
RX   PubMed=12213830; DOI=10.1074/jbc.m208210200;
RA   Xiao B., Masumiya H., Jiang D., Wang R., Sei Y., Zhang L., Murayama T.,
RA   Ogawa Y., Lai F.A., Wagenknecht T., Chen S.R.;
RT   "Isoform-dependent formation of heteromeric Ca2+ release channels
RT   (ryanodine receptors).";
RL   J. Biol. Chem. 277:41778-41785(2002).
RN   [7]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=16176801; DOI=10.1016/j.bbrc.2005.09.027;
RA   Conti A., Reggiani C., Sorrentino V.;
RT   "Selective expression of the type 3 isoform of ryanodine receptor Ca2+
RT   release channel (RyR3) in a subset of slow fibers in diaphragm and cephalic
RT   muscles of adult rabbits.";
RL   Biochem. Biophys. Res. Commun. 337:195-200(2005).
RN   [8]
RP   FUNCTION, INTERACTION WITH CALM, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=16274254; DOI=10.1021/bi051251t;
RA   Yamaguchi N., Xu L., Pasek D.A., Evans K.E., Chen S.R., Meissner G.;
RT   "Calmodulin regulation and identification of calmodulin binding region of
RT   type-3 ryanodine receptor calcium release channel.";
RL   Biochemistry 44:15074-15081(2005).
RN   [9]
RP   INTERACTION WITH SELENON, AND SUBCELLULAR LOCATION.
RX   PubMed=18713863; DOI=10.1073/pnas.0806015105;
RA   Jurynec M.J., Xia R., Mackrill J.J., Gunther D., Crawford T.,
RA   Flanigan K.M., Abramson J.J., Howard M.T., Grunwald D.J.;
RT   "Selenoprotein N is required for ryanodine receptor calcium release channel
RT   activity in human and zebrafish muscle.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:12485-12490(2008).
CC   -!- FUNCTION: Calcium channel that mediates the release of Ca(2+) from the
CC       sarcoplasmic reticulum into the cytoplasm in muscle and thereby plays a
CC       role in triggering muscle contraction. May regulate Ca(2+) release by
CC       other calcium channels. Calcium channel that mediates Ca(2+)-induced
CC       Ca(2+) release from the endoplasmic reticulum in non-muscle cells.
CC       Plays a role in cellular calcium signaling. Contributes to cellular
CC       calcium ion homeostasis. Isoform 2 lacks a predicted transmembrane
CC       segment and does not form functional calcium channels by itself;
CC       however, it can form tetramers with isoforms that contain the full
CC       complement of transmembrane segments and modulate their activity.
CC       {ECO:0000269|PubMed:10358090, ECO:0000269|PubMed:12213830,
CC       ECO:0000269|PubMed:12471029, ECO:0000269|PubMed:16274254,
CC       ECO:0000269|PubMed:9305876, ECO:0000269|PubMed:9614063}.
CC   -!- SUBUNIT: Homotetramer. Isoform 2 can form tetramers with isoform 1.
CC       Heterotetramer with RYR2. Interacts with FKBP1A. Interacts with CALM.
CC       Interacts with SELENON (PubMed:18713863). {ECO:0000269|PubMed:10358090,
CC       ECO:0000269|PubMed:12213830, ECO:0000269|PubMed:12471029,
CC       ECO:0000269|PubMed:16274254, ECO:0000269|PubMed:18713863,
CC       ECO:0000269|PubMed:9614063}.
CC   -!- INTERACTION:
CC       Q9TS33; Q9TS33: -; NbExp=2; IntAct=EBI-9542578, EBI-9542578;
CC   -!- SUBCELLULAR LOCATION: Sarcoplasmic reticulum membrane; Multi-pass
CC       membrane protein. Membrane; Multi-pass membrane protein. Microsome
CC       membrane; Multi-pass membrane protein. Sarcoplasmic reticulum
CC       {ECO:0000269|PubMed:18713863}. Note=The number of predicted
CC       transmembrane domains varies between orthologs, but both N-terminus and
CC       C-terminus seem to be cytoplasmic. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=Q9TS33-1; Sequence=Displayed;
CC       Name=2; Synonyms=AS-8a;
CC         IsoId=Q9TS33-2; Sequence=VSP_042306;
CC       Name=3;
CC         IsoId=Q9TS33-3; Sequence=VSP_042305;
CC       Name=4;
CC         IsoId=Q9TS33-4; Sequence=VSP_042307;
CC   -!- TISSUE SPECIFICITY: Detected in skeletal muscle from young rabbits and
CC       in adult diaphragm muscle (at protein level). Detected in brain,
CC       especially in corpus striatum, thalamus and hippocampus. Detected in
CC       taenia coli, uterus, vas deferens, aorta, stomach, small intestine,
CC       heart, diaphragm and ureter. Isoform 2 is highly expressed in uterus
CC       and aorta, and at much lower levels in heart, brain and diaphragm.
CC       {ECO:0000269|PubMed:10358090, ECO:0000269|PubMed:12471029,
CC       ECO:0000269|PubMed:1330694, ECO:0000269|PubMed:16176801,
CC       ECO:0000269|PubMed:16274254, ECO:0000269|PubMed:9305876}.
CC   -!- DEVELOPMENTAL STAGE: Ubiquitous in skeletal muscle in neonates and in
CC       15 day old rabbits. In adult, detected in diaphragm muscle, and in a
CC       subset of skeletal muscles including digastricus, pterygoideus, tongue
CC       and masseter. {ECO:0000269|PubMed:16176801}.
CC   -!- DOMAIN: The calcium release channel activity resides in the C-terminal
CC       region while the remaining part of the protein resides in the
CC       cytoplasm. {ECO:0000305|PubMed:10358090}.
CC   -!- MISCELLANEOUS: Channel activity is modulated by the alkaloid ryanodine
CC       that binds to the open calcium-release channel with high affinity. At
CC       low concentrations, ryanodine maintains the channel in an open
CC       conformation. High ryanodine concentrations inhibit channel activity.
CC       Channel activity is regulated by calmodulin (CALM). The calcium release
CC       is activated by elevated cytoplasmic calcium levels in the micromolar
CC       range, by caffeine and adenine nucleotides, such as AMP and ATP.
CC       Inhibited by Mg(2+) and ruthenium red.
CC   -!- MISCELLANEOUS: [Isoform 2]: Lacks a predicted transmembrane segment and
CC       does not form functional calcium channels. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the ryanodine receptor (TC 1.A.3.1) family. RYR3
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X68650; CAC16153.1; -; mRNA.
DR   PIR; S27272; S27272.
DR   RefSeq; NP_001076231.1; NM_001082762.1. [Q9TS33-1]
DR   SMR; Q9TS33; -.
DR   ComplexPortal; CPX-3157; Ryanodine 3 complex. [Q9TS33-1]
DR   STRING; 9986.ENSOCUP00000009882; -.
DR   GeneID; 100009545; -.
DR   KEGG; ocu:100009545; -.
DR   CTD; 6263; -.
DR   eggNOG; KOG2243; Eukaryota.
DR   OrthoDB; 3144451at2759; -.
DR   Proteomes; UP000001811; Unplaced.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0016529; C:sarcoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0033017; C:sarcoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005219; F:ryanodine-sensitive calcium-release channel activity; IDA:UniProtKB.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006874; P:cellular calcium ion homeostasis; TAS:UniProtKB.
DR   GO; GO:0071318; P:cellular response to ATP; IDA:UniProtKB.
DR   GO; GO:0071313; P:cellular response to caffeine; IDA:UniProtKB.
DR   GO; GO:0071277; P:cellular response to calcium ion; IDA:UniProtKB.
DR   GO; GO:0071286; P:cellular response to magnesium ion; IDA:UniProtKB.
DR   GO; GO:0006936; P:muscle contraction; NAS:UniProtKB.
DR   GO; GO:0051289; P:protein homotetramerization; IDA:UniProtKB.
DR   CDD; cd12877; SPRY1_RyR; 1.
DR   CDD; cd12879; SPRY3_RyR; 1.
DR   Gene3D; 1.10.287.70; -; 1.
DR   Gene3D; 1.10.490.160; -; 2.
DR   Gene3D; 2.60.120.920; -; 3.
DR   Gene3D; 2.80.10.50; -; 2.
DR   Gene3D; 6.20.350.10; -; 1.
DR   Gene3D; 1.10.238.10; EF-hand; 1.
DR   Gene3D; 1.25.10.30; IP3 receptor type 1 binding core, RIH domain; 1.
DR   InterPro; IPR001870; B30.2/SPRY.
DR   InterPro; IPR043136; B30.2/SPRY_sf.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR014821; Ins145_P3_rcpt.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR036300; MIR_dom_sf.
DR   InterPro; IPR016093; MIR_motif.
DR   InterPro; IPR013662; RIH_assoc-dom.
DR   InterPro; IPR000699; RIH_dom.
DR   InterPro; IPR013333; Ryan_recept.
DR   InterPro; IPR015925; Ryanodine_IP3_receptor.
DR   InterPro; IPR003032; Ryanodine_rcpt.
DR   InterPro; IPR009460; Ryanrecept_TM4-6.
DR   InterPro; IPR035910; RyR/IP3R_RIH_dom_sf.
DR   InterPro; IPR035761; SPRY1_RyR.
DR   InterPro; IPR035762; SPRY3_RyR.
DR   InterPro; IPR003877; SPRY_dom.
DR   PANTHER; PTHR46399; B30.2/SPRY DOMAIN-CONTAINING PROTEIN; 1.
DR   PANTHER; PTHR46399:SF9; RYANODINE RECEPTOR 3; 1.
DR   Pfam; PF08709; Ins145_P3_rec; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF02815; MIR; 1.
DR   Pfam; PF08454; RIH_assoc; 1.
DR   Pfam; PF06459; RR_TM4-6; 1.
DR   Pfam; PF01365; RYDR_ITPR; 2.
DR   Pfam; PF02026; RyR; 4.
DR   Pfam; PF00622; SPRY; 3.
DR   PRINTS; PR00795; RYANODINER.
DR   SMART; SM00472; MIR; 4.
DR   SMART; SM00449; SPRY; 3.
DR   SUPFAM; SSF49899; Concanavalin A-like lectins/glucanases; 3.
DR   SUPFAM; SSF47473; EF-hand; 1.
DR   SUPFAM; SSF100909; IP3 receptor type 1 binding core, domain 2; 2.
DR   SUPFAM; SSF82109; MIR domain; 2.
DR   PROSITE; PS50188; B302_SPRY; 3.
DR   PROSITE; PS50919; MIR; 5.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Calmodulin-binding; Endoplasmic reticulum; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Microsome; Receptor;
KW   Reference proteome; Repeat; Sarcoplasmic reticulum; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN           1..4872
FT                   /note="Ryanodine receptor 3"
FT                   /id="PRO_0000415649"
FT   TOPO_DOM        1..4188
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        4189..4209
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        4412..4432
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        4487..4507
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        4612..4632
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        4635..4655
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        4674..4694
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   INTRAMEM        4725..4734
FT                   /note="Pore-forming"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        4755..4775
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        4776..4872
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          100..155
FT                   /note="MIR 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00131"
FT   DOMAIN          162..207
FT                   /note="MIR 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00131"
FT   DOMAIN          215..269
FT                   /note="MIR 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00131"
FT   DOMAIN          275..333
FT                   /note="MIR 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00131"
FT   DOMAIN          343..400
FT                   /note="MIR 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00131"
FT   DOMAIN          585..796
FT                   /note="B30.2/SPRY 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00548"
FT   REPEAT          840..953
FT                   /note="1"
FT   REPEAT          954..1068
FT                   /note="2"
FT   DOMAIN          1012..1208
FT                   /note="B30.2/SPRY 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00548"
FT   DOMAIN          1254..1466
FT                   /note="B30.2/SPRY 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00548"
FT   REPEAT          2592..2710
FT                   /note="3"
FT   REPEAT          2711..2823
FT                   /note="4"
FT   REGION          840..2823
FT                   /note="4 X approximate repeats"
FT   REGION          2325..2338
FT                   /note="Interaction with FKBP1A"
FT                   /evidence="ECO:0000250"
FT   REGION          3472..3501
FT                   /note="Interaction with CALM"
FT                   /evidence="ECO:0000269|PubMed:16274254"
FT   REGION          3587..3615
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          4104..4124
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          4305..4358
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        4110..4124
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        4316..4358
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            3885
FT                   /note="Important for activation by Ca(2+)"
FT   VAR_SEQ         3341..3345
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:12471029,
FT                   ECO:0000303|PubMed:9305876"
FT                   /id="VSP_042305"
FT   VAR_SEQ         4406..4434
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12471029"
FT                   /id="VSP_042306"
FT   VAR_SEQ         4791..4841
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:12471029"
FT                   /id="VSP_042307"
FT   MUTAGEN         3885
FT                   /note="E->A: Reduces calcium-sensitivity by over
FT                   10000-fold."
FT                   /evidence="ECO:0000269|PubMed:9614063"
SQ   SEQUENCE   4872 AA;  551929 MW;  D1DC6B85CD6B93E6 CRC64;
     MAEGGEGGED EIQFLRTEDE VVLQCIATVH KEQRKFCLAA EGLGNRLCFL EPTSEAKFIP
     PDLCVCNFVL EQSLSVRALQ EMLANTGENG GEGAAQGGGH RTLLYGHAIL LRHSFSGMYL
     TCLTTSRSQT DKLAFDVGLR EHATGEACWW TIHPASKQRS EGEKVRIGDD LILVSVSSER
     YLHLSISNGN IQVDASFMQT LWNVHPTCSG SSIEEGYLLG GHVVRLFHGH DECLTIPSTD
     QNDSQHRRIF YEAGGAGTRA RSLWRVEPLR ISWSGSNIRW GQAFRLRHLT TGHYLALTED
     QGLLLQDRGK ADTKSTAFSF RPSKETKEKL DSSHKRDIEG MGVPEIKYGD SVCFVQHIAS
     GLWVTYKAQD AKTSRLGPLK RKVILHQEGH MDDGLTLQRC QREESQAARI IRNTTALFSQ
     FVSGNNRTAA PVTLPIEEVL QTLHDLIAYF QPPEEEMQHE DKQNKLRSLK NRQNLFKEEG
     MLALVLNCID RLNIYNSVAH FAGIAREESG MAWKEVLSLL YKLLAALIRG NRNTCAQFSN
     NLDWLISKLD RLESSSGILE VLHCILIESP EALNLIAEGH IKSIISLLDK HGRNHKVLDV
     LCSLCLCNGV AVRANQNLIC DNLLPRRNLL LQTRLINDVT SIRPNIFLGV AEGSAQYKKW
     YFELIIDQVD PFLTAEPTHL RVGWASSSGY APYPGGGEGW GGNGVGDDLY SYGFDGLHLW
     SGRIPRAVAS INQHLLKSDD VVSCCLDLGV PSISFRINGQ PVQGMFENFN TDGLFFPVMS
     FSAGVKVRFL MGGRHGEFKF LPPSGYAPCY EALLPKEKMR LEPVKEYKRD AEGVRDLLGT
     TQFLSQASFI PCPIDTSQVV LPPHLEKIRD RLAENIHELW GMNKIELGWT FGKMRDDNKR
     QHPCLVEFSK LPETEKNYNL QMSTETLKTL LALGCHIAHV NPAAEEDLKK VKLPKNYMMS
     NGYKPAPLDL SDVKLLPPQE ILVDKLAENA HNVWAKDRIK QGWTYGIQQD LKNKRNPRLV
     PYALLDERTK KSNRDSLREA VRTFVGYGYN IEPSDQELAD PAVEKVSIDK IRFFRVERSY
     AVRSGKWYFE FEVVTGGDMR VGWARPGCRP DIELGPMTKP LCLKAAGASV GTKVVGILGV
     PWQPGDVVGC MINLDDASMI FTLNGELLIT NKGSELAFAD YEIENGFVPI CSLGLSQIGR
     MNLGTDASTF KFYTMCGLQE GFEPFAVNMN RDVAMWFSKR LPTFVNVPKD HPHIEVVRID
     GTMDSPPCLK VTHKTFGTQN SNANMIYCRL SMPVECHSSF SHSPCLDSEA FQKRKQMQEI
     LSHTTTQCFY SIRIFAGQDP SCVWVGWVTP DYHLYSEKFD LNKNCTVTVT LGDERGRVHE
     SVKRSNCYMV WGGDVVASSQ RSSRSNVDLE IGCLVDLAMG MLSFSANGKE LGTCYQVEPN
     TKVFPAVFLQ PTSTSLFQFE LGKLKNAMPL SAAIFKSEEK NPVPQCPPRL DVQTIQPVLW
     SRMPNSFLKV ETERVSERHG WVVQCLEPLQ MMALHIPEEN RCVDILELCE QEDLMQFHYH
     TLRLYSAVCA LGNSRVAYAL CSHVDLSQLF HAIDNKYLPG LLRSGFYDLL ISIHLANAKE
     RKLMMKNEYI IPITSTTRNI RLYPDESKKH GLPGVGPRTC LKPGFKFSTP CFVVTNEERQ
     KQSPEIPLEI LKMKALSMLT EAVQCSGAHI RDPVGGSVEF QFVPVLKLVG TLLVMGVFCD
     DDVRQILLLI DPSVFGEHSA DTEEGAEKEE VSQVEEKAVE AGEKTSKEAR KEAPVRGLLQ
     TRLPESVKLQ MCELLSYLCD CELQHRVEAI VAFGDIYVSK LQANQKFRYN ELMQALNMSA
     ALTARKTREF RSPPQEQINM LLNFQLGENC PCPEEIREEL YDFHEDLLVH CGVPLEEEEE
     EEEDTSWTGK LRTLVYKIKG PPKPEKEQPT EEEERCPTTL KELISQTMIR WAQEDQIQDA
     ELVRMMFNLL RRQYDSIGEL LQALRKTYTI SHASVSDTIN LLAALGQIRS LLSVRMGREE
     ELLMINGLGD IMNNKVFYQH PNLMRVLGMH ETVMEVMVNV LGTEKSQIAF PKMVASCCRF
     LCYFCRISRQ NQKAMFEHLS YLLENSSVGL ASPSMRGSTP LDVAASSVMD NNELALGLEE
     PDLEKVVTYL AGCGLQSCPM LLAKGYPDVG WNPIEGERYL SFLRFAVFVN SESVEENASV
     VVKLLIRRPE CFGPALRGEG GNGLLAAMQG AIKISESPAL DLPSQGYKRE VPEDGEEEEE
     IVHMGNAIMS FYSALIDLLG RCAPEMHLIQ TGKGEAIRIR SILRSLVPTE DLVGIISIPL
     KLPSLNKDGS VSEPDMAANF CPDHKAPMVL FLDRVYGIKD QTFLLHLLEV GFLPDLRASA
     SLDTVALSTT ESALALNRYI CSAVLPLLTR CAPLFAGTEH YTSLIDSTLQ TIYRLSKGRS
     LTKAQRDTIE ECLLAICNHL RPSMLQQLLR RLVFDVPQLN DYCKMPLKLL TNHFEQCWKY
     YCLPSGWGSY GLAVEEELHL TEKLFWGIFD SLSHKKYDPD LFRMSLPCLS AIAGALPPDY
     LDTRITATLE KQVSVDADGN FDPKPINTIN FSLPEKLEYI VTKYAEHSHD KWACEKSQSG
     WKYGISLDEN VKTHPLIRPF KTLTEKEKEI YRWPARESLK TMLAVGWTVE RTKEGEALVQ
     LRENEKLRSV SQTSQGNSYN PAPLDLSNVV LSRELQGMVE VVAENYHNIW AKKKKLELES
     KGGGSHPLLV PYDTLTAKEK FRDREKAQDL FKFLQVNGVI VSRGMKDMEL DAFSMEKRFA
     YKFLKKILKY VDSAQEFIAH LEAIVSSGKT EKSPHDQEIK FFAKVLLPLV DQYFTNHRLY
     FLSSPLKPLS SSGYASHKEK EMVASLFCKL AALVRHRISL FGSDSTTMVS CLHILAQTLD
     TRTVMKSGSE LVKAGLRAFF ESAAEDLEKT SENLKLGKFT HSRTQIKGVS QNINYTTVAL
     LPILTSIFEH VAQHQFGVDL LLGDVQISCY RILCSLYSLG TGKNIYVERQ RPALGECLAS
     LAAAIPVAFL EPTLNRYNAL SVFNTKTPRE RSILGMPDTV EEMCPDIPQL EGLMKEINDL
     AESGARYTEM PHVIEVILPM LCNYLSYWWE RGPENLSPST GPCCSKVTSE HLSLILGNIL
     KIINNNLGID EASWMKRIAV YAQPIISKAR PDLLRSHFIP TLEKLKKKAV KTVQEEEQLK
     ADGKGDTQEA ELLILDEFAI LCRDLYAFYP MLIRYVDNNR SNWLKSPDGD SDQLFRMVAE
     VFILWCKSHN FKREEQNFVI QNEINNLAFL TGDSKSKMSK AMQVKSGGQD QERKKTKRRG
     DLYSIQTSLI VAALKKMLPI GLNMCTPGDQ ELISLAKSRY SYRDTDEEVK EHLRNNLHLQ
     EKSDDPAVKW QLNLYKDVLK SEEPSNPEKT VERVQRISAA VFHLEQVEQP LRSKKAVWHK
     LLSKQRKRAV VACFRMAPLY NLPRHRSINL FLHGYQRFWI ETEEYSFEEK LVQDLAKSPK
     VEEEEEEEME KQPDPLHQII LHFSRNALTE RSKLEDDPLY TSYSSMMAKS CQSGEDEEEE
     DKEKTFEEKE MEKQKTLYQQ ARLHERGAAE MVLQMISASK GEMSPMVVET LKLGIAILNG
     GNAGVQQKML DYLKVKKDAG FFQSLSGLMQ SCSVLDLNAF ERQNKAEGLG MVTEEGTLIV
     RERGEKVLQN DEFTRDLFRF LQLLCEGHNS DFQNFLRTQM GNTTTVNVII STVDYLLRLQ
     ESISDFYWYY SGKDIIDESG QHNFSKALAV TKQIFNSLTE YIQGPCIGNQ QSLAHSRLWD
     AVVGFLHVFA NMQMKLSQDS SQIELLKELL DLLQDMVVML LSLLEGNVVN GTIGKQMVDT
     LVESSTNVEM ILKFFDMFLK LKDLTSSDTF KEYDPDGKGI ISKKEFQKAM EGQKQYTQSE
     IDFLLSCAEA DENDMFNYID FVDRFHEPAK DIGFNVAVLL TNLSEHMPND SRLKCLLDPA
     ESVLNYFEPY LGRIEIMGGA KKIERVYFEI SESSRTQWEK PQVKESKRQF IFDVVNEGGE
     QEKMELFVNF CEDTIFEMQL ASQISESDSA DRPEEEEGDE ESSYVLEING EEEEDKSFES
     ASAFAMACAS LKRNITNLLR KATLKNLRKQ YRNVKKMTAK ELVKVFFSFF WMLFVGLFQL
     FFTIVGGIFQ ILWSTVFGGG LVEGAKNIRV TKILGDMPDP TQFGIHDDAM EAERAEVAEA
     GITTELVHFV KGERGDTELM SDLFGLHPKK EGGVKHGPEV GLGDLSEIIG KDEPPTLEST
     VRKKRKAQAA ETKAEHEAEG KVESEKADLE DGEKEDKAKE EERAEYLWAE VTKKKKRRRG
     QKVEKPEAFM ANFFKGLEIY QTKLLHYLAR NFYNLRFLAL FVAFAINFIL LFYKVTEEPL
     EEETEDVANL WNSLNDEEEE EAMVFFVLQE STGYMAPTLR ALAVVHTIIS LVCVVGYYCL
     KVPLVVFKRE KEIARKLEFD GLYITEQPSE DDIKGQWDRL VINTPSFPHN YWDKFVKRKV
     INKYGDLYGA ERIAELLGLD KNALDFSPVE ETTAEAASLV SWLSSIDMKY HIWKLGVVFT
     DNSFLYLAWY TTMSVLGHYN NFFFAAHLLD IAMGFKTLRT ILSSVTHNGK QLVLTVGLLA
     VVVYLYTVVA FNFFRKFYNK SEDDDEPDMK CDDMMTCYLF HMYVGVRAGG GIGDEIEDPA
     GDPYEMYRIV FDITFFFFVI VILLAIIQGL IIDAFGELRD QQEQVREDME TKCFICGIGN
     DYFDTTPHGF ETHTLQEHNL ANYLFFLMYL INKDETEHTG QESYVWKMYQ ERCWDFFPAG
     DCFRKQYEDQ LG
//
